<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(6)</volume><submitter>Akhtar N</submitter><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>Understanding the relationship of COVID-19 to stroke is important. We compare characteristics of pre-pandemic historical stroke (Pre-C), cases in acute COVID infection (Active-C) and in patients who have recovered from COVID-19 infection (Post-C).&lt;h4>Methods&lt;/h4>We interrogated the Qatar stroke database for all stroke admissions between Jan 2019 and Feb 2020 (Pre-C) to Active-C (Feb2020-Feb2021) and Post-C to determine how COVID-19 affected ischemic stroke sub-types, clinical course, and outcomes prior to, during and post-pandemic peak. We used the modified Rankin Scale (mRS) to measure outcome at 90-days (mRS 0-2 good recovery and mRS 3-6 as poor recovery). For the current analysis, we compared the clinical features and prognosis in patients with confirmed acute ischemic stroke.&lt;h4>Results&lt;/h4>There were 1413 cases admitted (pre-pandemic: 1324, stroke in COVID-19: 46 and recovered COVID-19 stroke: 43). Patients with Active-C were significantly younger, had more severe symptoms, fever on presentation, more ICU admissions and poor stroke recovery at discharge when compared to Pre-C and Post-C. Large vessel disease and cardioembolic disease was significantly more frequent in Active-C compared to PRE-C or post-C.&lt;h4>Conclusions&lt;/h4>Stroke in Post-C has characteristics similar to Pre-C with no evidence of lasting effects of the virus on the short-term. However, Active-C is a more serious disease and tends to be more severe and have a poor prognosis.</pubmed_abstract><journal>PloS one</journal><pagination>e0270413</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9232148</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ischemic stroke in patients that recover from COVID-19: Comparisons to historical stroke prior to COVID-19 or stroke in patients with active COVID-19 infection.</pubmed_title><pmcid>PMC9232148</pmcid><pubmed_authors>Shabir H</pubmed_authors><pubmed_authors>Abid F</pubmed_authors><pubmed_authors>Shuaib A</pubmed_authors><pubmed_authors>Morgan D</pubmed_authors><pubmed_authors>Joseph S</pubmed_authors><pubmed_authors>Al Attar R</pubmed_authors><pubmed_authors>Kamran S</pubmed_authors><pubmed_authors>Salamah S</pubmed_authors><pubmed_authors>AlMaslamani M</pubmed_authors><pubmed_authors>Imam Y</pubmed_authors><pubmed_authors>Yasir M</pubmed_authors><pubmed_authors>Al-Jerdi S</pubmed_authors><pubmed_authors>Akhtar N</pubmed_authors><pubmed_authors>Singh R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ischemic stroke in patients that recover from COVID-19: Comparisons to historical stroke prior to COVID-19 or stroke in patients with active COVID-19 infection.</name><description>&lt;h4>Background and purpose&lt;/h4>Understanding the relationship of COVID-19 to stroke is important. We compare characteristics of pre-pandemic historical stroke (Pre-C), cases in acute COVID infection (Active-C) and in patients who have recovered from COVID-19 infection (Post-C).&lt;h4>Methods&lt;/h4>We interrogated the Qatar stroke database for all stroke admissions between Jan 2019 and Feb 2020 (Pre-C) to Active-C (Feb2020-Feb2021) and Post-C to determine how COVID-19 affected ischemic stroke sub-types, clinical course, and outcomes prior to, during and post-pandemic peak. We used the modified Rankin Scale (mRS) to measure outcome at 90-days (mRS 0-2 good recovery and mRS 3-6 as poor recovery). For the current analysis, we compared the clinical features and prognosis in patients with confirmed acute ischemic stroke.&lt;h4>Results&lt;/h4>There were 1413 cases admitted (pre-pandemic: 1324, stroke in COVID-19: 46 and recovered COVID-19 stroke: 43). Patients with Active-C were significantly younger, had more severe symptoms, fever on presentation, more ICU admissions and poor stroke recovery at discharge when compared to Pre-C and Post-C. Large vessel disease and cardioembolic disease was significantly more frequent in Active-C compared to PRE-C or post-C.&lt;h4>Conclusions&lt;/h4>Stroke in Post-C has characteristics similar to Pre-C with no evidence of lasting effects of the virus on the short-term. However, Active-C is a more serious disease and tends to be more severe and have a poor prognosis.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T19:13:15.373Z</modification><creation>2025-04-04T19:13:15.373Z</creation></dates><accession>S-EPMC9232148</accession><cross_references><pubmed>35749524</pubmed><doi>10.1371/journal.pone.0270413</doi></cross_references></HashMap>